These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 32048973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease.
    Xie J, Wang H, Lin T, Bi B.
    Biomed Res Int; 2017; 2017():2986460. PubMed ID: 28473983
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT, MacPherson KP, Reed-Geaghan EG, Landreth GE.
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Microglia and amyloid plaque formation in Alzheimer's disease - Evidence, possible mechanisms, and future challenges.
    Fruhwürth S, Zetterberg H, Paludan SR.
    J Neuroimmunol; 2024 May 15; 390():578342. PubMed ID: 38640827
    [Abstract] [Full Text] [Related]

  • 11. Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques.
    Natunen T, Martiskainen H, Marttinen M, Gabbouj S, Koivisto H, Kemppainen S, Kaipainen S, Takalo M, Svobodová H, Leppänen L, Kemiläinen B, Ryhänen S, Kuulasmaa T, Rahunen E, Juutinen S, Mäkinen P, Miettinen P, Rauramaa T, Pihlajamäki J, Haapasalo A, Leinonen V, Tanila H, Hiltunen M.
    Mol Neurodegener; 2020 Nov 10; 15(1):66. PubMed ID: 33168021
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W, Abud EA, Yeung ST, Lakatos A, Nassi T, Wang J, Blum D, Buée L, Poon WW, Blurton-Jones M.
    Acta Neuropathol Commun; 2016 Jun 23; 4(1):63. PubMed ID: 27339073
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
    Paasila PJ, Davies DS, Kril JJ, Goldsbury C, Sutherland GT.
    Brain Pathol; 2019 Nov 23; 29(6):726-740. PubMed ID: 30803086
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.
    Gerrits E, Brouwer N, Kooistra SM, Woodbury ME, Vermeiren Y, Lambourne M, Mulder J, Kummer M, Möller T, Biber K, Dunnen WFAD, De Deyn PP, Eggen BJL, Boddeke EWGM.
    Acta Neuropathol; 2021 May 23; 141(5):681-696. PubMed ID: 33609158
    [Abstract] [Full Text] [Related]

  • 18. Zinc utilization by microglia in Alzheimer's disease.
    Shippy DC, Oliai SF, Ulland TK.
    J Biol Chem; 2024 May 23; 300(5):107306. PubMed ID: 38648940
    [Abstract] [Full Text] [Related]

  • 19. Dynamic Change of Intracellular Metabolism of Microglia Evaluated by Transcriptomics in an Alzheimer's Mouse Model.
    Qiu H, Zhao R, Fei G, Pan X, Sang S, Xu Y, Jin B, Jin L, Cheng X, Zhong C.
    J Alzheimers Dis; 2021 May 23; 81(2):517-531. PubMed ID: 33814454
    [Abstract] [Full Text] [Related]

  • 20. Transposable elements and Alzheimer's disease pathogenesis.
    Evering TH, Marston JL, Gan L, Nixon DF.
    Trends Neurosci; 2023 Mar 23; 46(3):170-172. PubMed ID: 36588011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.